Mark Van Oene Insider Profile
4 Followers
Mark Van Oene, President & CEO at Pacific Biosciences, holds 2.71M shares in Pacific Biosciences (Ticker: PACB), holds 16.57K shares in Illumina (Ticker: ILMN). Most recently, Mark Van Oene Sold ― shares of Pacific Biosciences on Aug 18, 2026 for an estimated value of $30.41K.
Mark Van Oene Pacific Biosciences (PACB)President & CEO
Pacific Biosciences (PACB)
President & CEO
Ranked #8,566 out of 108,814 Corporate Insiders
Profitable Transactions
7 out of 8 Profitable Transactions
Average Return
+28.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Van Oene holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 18, 2023 - Aug 18, 2024
Return:+84.90%
The most profitable trade made by Mark Van Oene
Mark Van Oene's Trading History
Pacific Biosciences
Aug 18, 2026
President & CEO
Informative Sell
30.41K
$3.46M
Illumina
Nov 09, 2020
SVP Chief Commercial Officer
Uninformative Sell
334.48K
$3.43M
List of latest transactions for each holding click on a transaction to see Mark Van Oene's performance on stock
You May Also Like
Mark Van Oene insider profile FAQ
What is the percentage of profitable transactions made by Mark Van Oene?
The percentage of profitable transactions made by Mark Van Oene is 88%.
What is the average return per transaction made by Mark Van Oene?
The average return per transaction made by Mark Van Oene is 28.20%.
What stocks does Mark Van Oene hold?
Mark Van Oene holds: PACB, ILMN stocks.
What was Mark Van Oene’s latest transaction?
Mark Van Oene latest transaction was an Informative Sell of $30.41K.
What was Mark Van Oene's most profitable transaction?
Mark Van Oene’s most profitable transaction was an Informative Sell of PACB stock on August 18, 2023. The return on the trade was 84.90%.
What is Mark Van Oene's role in Pacific Biosciences?
Mark Van Oene's role in Pacific Biosciences is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.